Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis

BACKGROUND: To evaluate whether the addition of taxanes to platinum and fluoropyrimidines in adjuvant chemotherapy would result in longer survival than platinum plus fluoropyrimidines in gastric cancer patients who received D2 gastrectomy. METHODS: Data of patients with gastric adenocarcinoma who re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lili, Feng, Ying, Wu, Zhijun, Xu, Hui, Zhang, Cheng, Ning, Jie, Wang, Rong, Chen, Jianqiong, Xie, Minmin, Zhang, Yi, Bu, Lijia, Hao, Jiqing, Ma, Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434742/
https://www.ncbi.nlm.nih.gov/pubmed/34507562
http://dx.doi.org/10.1186/s12957-021-02390-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434742/
https://www.ncbi.nlm.nih.gov/pubmed/34507562
http://dx.doi.org/10.1186/s12957-021-02390-4

Ejemplares similares